Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US FDA Serves One Antacid/Analgesic Question For AdComm, Opens Tap On Hangover Discussion

Executive Summary

Presentations at the US nonprescription drugs/drug safety joint advisory committee meeting will come from Bayer, marketer of the OTC brand synonymous with antacid/aspirin formulations, Alka-Seltzer, and from a firm that markets Blowfish, a caffeine/aspirin OTC indicated as a hangover remedy.

Advertisement

Related Content

What’s Next For Antacid/Analgesic OTCs After Negative US FDA Panel?
Alka-Seltzer Antacid Will 'Plop, Plop Fizz, Fizz' Without Aspirin
Safety Review For Upset Stomach, Hangover OTCs Reconsiders Science

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS120353

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel